Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00USF
|
||||
| Former ID |
DAP000104
|
||||
| Drug Name |
Trazodone
|
||||
| Synonyms |
Beneficat; Desirel; Sideril; Tradozone; Trazalon; Trazodil; Trazodon; Trazodona; Trazodonum; Trazolan; Trazonil; Trialodine; Trittico; Desyrel Dividose; Trazodona [Spanish]; Trazodone Hcl; Trazodonum [Latin]; Beneficat (TN); Deprax (TN); Desirel (TN); Desyrel (TN); Desyrel(trazodone hcl salt); Molipaxin (TN); Thombran (TN); Trazodona [INN-Spanish]; Trazodone (Desyrel); Trazodone (INN); Trazodone [INN:BAN]; Trazodonum [INN-Latin]; Trazorel (TN); Trialodine (TN); Trittico (TN); 2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one; 2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one; 2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one; 8-[3-[4-(3-Chlorophenyl)piperazin-1-yl]propyl]-1,7,8-triazabicyclo[4.3.0]nona-2,4,6-trien-9-one hydrochloride
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Depression [ICD9: 311; ICD10:F30-F39] | Approved | [1], [2] | ||
| Therapeutic Class |
Antidepressants
|
||||
| Company |
Angelini research laboratories
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C19H22ClN5O
|
||||
| InChI |
InChI=1S/C19H22ClN5O/c20-16-5-3-6-17(15-16)23-13-11-22(12-14-23)8-4-10-25-19(26)24-9-2-1-7-18(24)21-25/h1-3,5-7,9,15H,4,8,10-14H2
|
||||
| InChIKey |
PHLBKPHSAVXXEF-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 19794-93-5
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
9365, 5659231, 7980825, 8153406, 11111900, 11111901, 11335371, 11360610, 11364318, 11366880, 11369442, 11372639, 11374249, 11377604, 11461582, 11466320, 11467440, 11484603, 11486179, 11488670, 11491375, 11492570, 11495238, 14828880, 24263015, 29224575, 46506648, 47216661, 47440129, 47515189, 47662138, 47736344, 47959598, 48184872, 48259097, 48259098, 49698420, 50057656, 50100361, 50104290, 56394831, 57322830, 75102958, 85209489, 85788818, 90341328, 92717483, 93619784, 96025310, 103188158
|
||||
| ChEBI ID |
ChEBI:9654
|
||||
| SuperDrug ATC ID |
N06AX05
|
||||
| SuperDrug CAS ID |
cas=019794935
|
||||
| Target and Pathway | |||||
| Target(s) | Sodium-dependent serotonin transporter | Target Info | Modulator | [3] | |
| 5-hydroxytryptamine 1A receptor | Target Info | Modulator | [3] | ||
| KEGG Pathway | Serotonergic synapsehsa04024:cAMP signaling pathway | ||||
| Neuroactive ligand-receptor interaction | |||||
| Serotonergic synapse | |||||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | 5HT1 type receptor mediated signaling pathway | ||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Reactome | Serotonin receptors | ||||
| G alpha (i) signalling events | |||||
| WikiPathways | Monoamine Transport | ||||
| SIDS Susceptibility Pathways | |||||
| NRF2 pathway | |||||
| Synaptic Vesicle Pathway | |||||
| Serotonin Transporter ActivityWP722:Serotonin HTR1 Group and FOS Pathway | |||||
| Monoamine GPCRs | |||||
| GPCRs, Class A Rhodopsin-like | |||||
| GPCR ligand binding | |||||
| GPCR downstream signaling | |||||
| References | |||||
| REF 1 | Emerging treatments for depression. Expert Opin Pharmacother. 2006 Dec;7(17):2323-39. | ||||
| REF 2 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 213). | ||||
| REF 3 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.